Correction to: Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast‑activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma

التفاصيل البيبلوغرافية
العنوان:	Correction to: Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast‑activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma
المؤلفون:	Jinghua, Li^{Aff1, Aff2}, Kui, Xu, Deliang, Guo^{Aff1, Aff2}, Bo, Liao^{Aff1, Aff2}, Qian, Zhu^{Aff1, Aff2}, Haitao, Wang^{Aff1, Aff2}, Yaqun, Jiang^{Aff2, Aff3}, Dongde, Wu, Xigang, Xia, Ping, Jiang^{Aff1, Aff2}, Shengli, Tang^{Aff1, Aff2}, Zhiyong, Yang^{Aff1, Aff2}, Yueming, He^{Aff1, Aff2}, Zhonglin, Zhang^{Aff1, Aff2, IDs00259023061882_cor14}, Yong, He^{Aff2, Aff3, IDs00259023061882_cor15}, Yufeng, Yuan^{Aff1, Aff2, Aff6, IDs00259023061882_cor16}
المصدر:	European Journal of Nuclear Medicine and Molecular Imaging. 50(7):2230-2230
قاعدة البيانات:	Springer Nature Journals

الوصف
تدمد:	16197070 16197089
DOI:	10.1007/s00259-023-06188-2